Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review.

Journal of cancer research and therapeutics - 1 Jan 2000

Gautam Nisha, Kaur Mandeep, Kaur Satbir

Abstract excerpt

Polycomb group proteins (PcG) are multi-subunit structure, consisting of polycomb repressive complex 1 (PRC1), PRC2/3, and pleiohomeotic repressive complex. PRC1 is made up of PHC, BMI-1, CBX, and Ring 1A/B. PRC2 protein complex included embryonic ectoderm development, PCL, SUZ12, SET domain, enhancer of zeste homolog-2 protein (EZH2), and Nurf55. The third subunit PhoRC consists of Pho and DSFMBT subunits. One...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast
Share to Breast Neoplasms
Share to Disease Progression

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Enhancer of Zeste Homolog 2 Protein

Share to Epigenesis, Genetic

Share to Gene Expression Regulation, Neoplastic

Share to Prostate

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 33063698
DOI: 10.4103/jcrt.JCRT_1090_19

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Structural assembly of Polycomb group protein and Insight of EZH2 in cancer progression: A review.PMID 33063698Read ↗

Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies.Semantic proximity Read ↗

Polycomb repressive complex's evolutionary conserved function: the role of EZH2 status and cellular background.Semantic proximity Read ↗

EZH2-associated tumor malignancy: A prominent target for cancer treatment.Semantic proximity Read ↗

Polycomb complexes in normal and malignant hematopoiesisSemantic proximity Read ↗

Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms.Semantic proximity Read ↗

Epigenetic regulation of signaling pathways in cancer: role of the histone methyltransferase EZH2.Semantic proximity Read ↗

Epigenetic balance of gene expression by Polycomb and COMPASS families.Semantic proximity Read ↗

Clinical Correlations of Polycomb Repressive Complex 2 in Different Tumor TypesSemantic proximity Read ↗

Targeting EZH2 in cancer.Semantic proximity Read ↗

The conserved N-terminal SANT1-binding domain (SBD) of EZH2 Regulates PRC2 ActivitySemantic proximity Read ↗

The conserved N-terminal SANT1-binding domain (SBD) of EZH2 regulates PRC2 activity.Semantic proximity Read ↗

Polycomb group proteins in cell cycle progression and cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.